Randomized Controlled Trial Evaluating an Incentive-based Community Eye-care Programme

Randomized Controlled Trial Evaluating an Incentive-based Community Eye-care Programme for Elderly With Visual Impairment

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03264885

Enrollment

140

Registered

2017-08-29

Start date

2014-01-01

Completion date

2018-01-01

Last updated

2019-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual Impairment

Brief summary

Elderly with visual impairment (VI) who undergo community eye screening often do not attend tertiary follow-up even if significant eye diseases are detected. Investigators evaluate an incentive-care scheme (ICS) to improve the attendance rates of tertiary eye-care visits of participants following community eye screening.

Detailed description

A randomized controlled study individuals with VI with baseline visual acuity (VA) and vision-related quality of life (VRQoL) assessed in the community. Participants were randomised to either receiving ICS or usual care (UC). ICS is a novel intervention that incorporates patient education, social support, and financial assistance to assist individuals. Participants in UC received a standard GP referral letter advising them to seek further care. Our main outcome measure was compliance to tertiary eye-care referral. Our secondary outcome measure was VA and VRQoL assessed at 3 months.

Interventions

OTHERIncentive Care

ICS is a novel intervention that incorporates patient education, social support, and financial assistance to assist individuals.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

21 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* the ability to speak English and/or Mandarin, have adequate hearing with/without hearing aids to respond to normal conversation, not currently undergoing regular assessment/care with an ophthalmologist (at least yearly), have the ability to undergo visual acuity testing and provide reliable results, and visual acuity of 6/12 or worse in either eye after best correction

Exclusion criteria

* refused informed consent and any other contraindication(s) as indicated by the general practitioner responsible for the participant

Design outcomes

Primary

Measure	Time frame	Description
Compliance to Tertiary Care Follow-up	3 months	Percentage of participants who attended follow-up

Secondary

Measure	Time frame	Description
Visual Acuity	3 months	Vision checked on Snellen chart

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026